Literature DB >> 24722539

Dietary extra-virgin olive oil and corn oil differentially modulate the mRNA expression of xenobiotic-metabolizing enzymes in the liver and in the mammary gland in a rat chemically induced breast cancer model.

Miguel Á Manzanares1, Montserrat Solanas, Raquel Moral, Raquel Escrich, Elena Vela, Irmgard Costa, Eduard Escrich.   

Abstract

High extra-virgin olive oil (EVOO) and corn oil diets differentially modulate experimental mammary carcinogenesis. We have investigated their influence on the initiation stage through the modulation of the expression of xenobiotic-metabolizing enzymes (XMEs) in the liver and the mammary gland. Female Sprague-Dawley rats were fed a low-fat (LF), high corn oil (HCO), or high EVOO (HOO) diet from weaning and gavaged with 7,12-dimethylbenz(a)anthracene (DMBA). The HCO diet increased the mRNA levels of the phase I enzymes CYP1A1, CYP1A2 and, to a lesser extent, CYP1B1, in the liver. The Aryl hydrocarbon receptor (AhR) seemed to be involved in this upregulated CYP1 expression. However, a slight trend toward an increase in the mRNA levels of the phase II enzymes GSTP1 and NQO1 was observed with the HOO diet. At least in the case of GSTP1, this effect was linked to an increased Nrf2 transactivation activity. This different regulation of the XMEs expression led, in the case of the HCO diet, to a balance between the production of active carcinogenic compounds and their inactivation tilted toward phase I, which would stimulate DMBA-induced cancer initiation, whereas the HOO diet was associated with a slower phase I metabolism accompanied by a faster phase II detoxification, thus reducing the output of the active compounds to the target tissues. In the mammary gland, the differential effects of diets may be conditioned by the state of cell differentiation, sexual maturity, and hormone metabolism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24722539     DOI: 10.1097/CEJ.0000000000000032

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

Review 1.  Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.

Authors:  Donato F Romagnolo; Kevin D Daniels; Jonathan T Grunwald; Stephan A Ramos; Catherine R Propper; Ornella I Selmin
Journal:  Mol Nutr Food Res       Date:  2016-06       Impact factor: 5.914

2.  Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.

Authors:  Tajamul Hussain; Salman Alrokayan; Upadhyay Upasna; Manickam Pavithrakumari; Jaganathan Jayapriya; Vijay Kumar Kutala; Shaik Mohammad Naushad
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

3.  Trianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.

Authors:  Animesh Mandal; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

4.  Assessment of the antioxidant activity of an olive oil total polyphenolic fraction and hydroxytyrosol from a Greek Olea europea variety in endothelial cells and myoblasts.

Authors:  Paraskevi Kouka; Alexandros Priftis; Dimitrios Stagos; Apostolis Angelis; Panagiotis Stathopoulos; Nikos Xinos; Alexios-Léandros Skaltsounis; Charalampos Mamoulakis; Aristides M Tsatsakis; Demetrios A Spandidos; Demetrios Kouretas
Journal:  Int J Mol Med       Date:  2017-07-20       Impact factor: 4.101

5.  Lipidomic Profile and Enzymes Activity in Hepatic Microsomes of Rats in Physiological and Pathological Conditions.

Authors:  Tomasz Lepionka; Małgorzata Białek; Marian Czauderna; Michał Szlis; Agnieszka Białek
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

Review 6.  Influence of Olive Oil and Its Components on Breast Cancer: Molecular Mechanisms.

Authors:  Raquel Moral; Eduard Escrich
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.